Abstract
There is strong interest to study the involvement of brain cannabinoid subtype-1 (CB1) receptors in neuropsychiatric disorders with single photon emission computed tomography (SPECT) and a suitable radioligand. Here we report the synthesis of a novel high-affinity radioiodinated CB1 receptor ligand ([125I]8, [125I]1-(2-iodophenyl)-4-cyano-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxylate, [125I]SD7015). By autoradiography in vitro, [125I]8 showed selective binding to CB1 receptors on human brain postmortem cryosections and now merits labeling with iodine-123 for further evaluation as a SPECT radioligand in non-human primate.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, N.I.H., Intramural
MeSH terms
-
Brain / diagnostic imaging*
-
Humans
-
Iodine Radioisotopes
-
Ligands*
-
Piperidines / chemical synthesis*
-
Piperidines / chemistry
-
Pyrazoles / chemical synthesis*
-
Pyrazoles / chemistry
-
Radiopharmaceuticals / chemical synthesis*
-
Radiopharmaceuticals / chemistry
-
Receptor, Cannabinoid, CB1 / chemistry
-
Receptor, Cannabinoid, CB1 / metabolism*
-
Tomography, Emission-Computed, Single-Photon
Substances
-
1-(2-iodophenyl)-4-cyano-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxylate
-
4-cyano-1-(2-iodophenyl)-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide
-
Iodine Radioisotopes
-
Ligands
-
Piperidines
-
Pyrazoles
-
Radiopharmaceuticals
-
Receptor, Cannabinoid, CB1